kidney issues with semaglutide Benefits of GLP-1 Semaglutide use tied to lower

For bone formation, PTH could increase osteoblast numbers and promote osteoblast activity [86-88]

Lowered A1C of 1.7%2.0% across doses Weight loss of 16.8% in the highest dose over 40 weeks without evidence of weight loss plateau The longer duration 80-week TRIUMPH-2 will more effectively evaluate the weight loss potential of retatrutide in those with type 2 diabetes and obesity, expected to result later this year Press release: Retatrutide Shows Promising Results in Type 2 Diabetes and Obesity Trial The next installment of the triple agonist retatrutide is here with more top-line phase 3 results

EmamiATofighiAAsri RezaeiSBazargani GilaniB

Janczar K, Tybor K, Jozefowicz M, et al

A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimers disease

Drug Metab Dispos : Epub ahead of print